Published in J Clin Invest on March 15, 1997
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J Med Genet (2006) 0.93
Lipoprotein (a) and stroke. J Clin Pathol (2000) 0.92
LPA and PLG sequence variation and kringle IV-2 copy number in two populations. Hum Hered (2008) 0.85
Structure, function, and genetics of lipoprotein (a). J Lipid Res (2016) 0.83
A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription. Biochem J (2004) 0.78
Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism. PLoS One (2016) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet (1983) 8.94
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature (1987) 4.54
The mysteries of lipoprotein(a). Science (1989) 3.45
A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. Acta Pathol Microbiol Scand (1963) 3.13
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest (1990) 2.16
Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA (1986) 2.08
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. J Clin Invest (1989) 1.55
Turnover of lipoprotein (a) in man. J Clin Invest (1980) 1.48
Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis (1986) 1.43
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A (1989) 1.37
Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet (1989) 1.34
Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis (1989) 1.34
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet (1992) 1.26
Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis (1990) 1.26
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest (1993) 1.17
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest (1994) 1.14
Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest (1992) 1.13
Lp(a): an interloper into the fibrinolytic system? Thromb Haemost (1990) 1.11
Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest (1994) 1.07
Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J Biol Chem (1991) 1.06
5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci U S A (1993) 1.02
Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry (1992) 0.99
Induction of translation by the 5'-untranslated region of human androgen receptor mRNA. J Biol Chem (1994) 0.97
Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen. Biochemistry (1989) 0.92
Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet (1995) 0.92
Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease. Am J Cardiol (1991) 0.91
C/T polymorphism in the 5' untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb Vasc Biol (1995) 0.89
Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest (1994) 0.89
Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry (1992) 0.84
Detection of polymorphisms in the 5'-flanking region of the gene for apolipoprotein(a). Biochem Biophys Res Commun (1995) 0.81
Apolipoprotein(a) gene transcription is regulated by liver-enriched trans-acting factor hepatocyte nuclear factor 1 alpha. J Biol Chem (1994) 0.81
Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation (1994) 0.80
Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age. Am J Cardiol (1994) 0.78
Characterization of the apolipoprotein(a) gene. Biochem Biophys Res Commun (1995) 0.77
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science (1995) 7.77
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics (1996) 6.83
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature (1986) 6.67
Green revolution: a mutant gibberellin-synthesis gene in rice. Nature (2002) 5.84
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 4.44
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology (1998) 4.29
Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve (1995) 3.84
Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex. Cell (1988) 3.59
An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med (1995) 3.42
Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet (1998) 3.38
Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol (1997) 2.89
Function of the 30 kd protein of tobacco mosaic virus: involvement in cell-to-cell movement and dispensability for replication. EMBO J (1987) 2.78
Cloning and complete nucleotide sequence of the Escherichia coli glutamine permease operon (glnHPQ). Mol Gen Genet (1986) 2.73
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70
Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J Exp Med (1996) 2.62
Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity (1994) 2.61
Hyperammonaemia and Helicobacter pylori. Lancet (1995) 2.59
Functionally related motor neuron pool and muscle sensory afferent subtypes defined by coordinate ETS gene expression. Cell (1998) 2.57
Temperature-induced A-B intersite charge transfer in an A-site-ordered LaCu(3)Fe(4)O(12) perovskite. Nature (2009) 2.57
An extracellular poly(3-hydroxybutyrate) depolymerase from Alcaligenes faecalis. Eur J Biochem (1982) 2.49
Mu1B, a novel adaptor medium chain expressed in polarized epithelial cells. FEBS Lett (1999) 2.37
The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J (1997) 2.34
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 2.31
Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res (1971) 2.29
Antigen-specific suppressive factor produced by a transplantable I-J bearing T-cell hybridoma. Nature (1979) 2.28
The medium subunits of adaptor complexes recognize distinct but overlapping sets of tyrosine-based sorting signals. J Biol Chem (1998) 2.21
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem (2000) 2.18
Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha beta-human T3 receptor complexes. Nature (1987) 2.11
Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol (2001) 2.09
Influence of dentition status on physical disability, mental impairment, and mortality in institutionalized elderly people. J Dent Res (2001) 2.06
Molecular cloning and characterization of a cDNA encoding the gibberellin biosynthetic enzyme ent-kaurene synthase B from pumpkin (Cucurbita maxima L.). Plant J (1996) 2.04
The Dictyostelium developmental cDNA project: generation and analysis of expressed sequence tags from the first-finger stage of development. DNA Res (1998) 2.03
Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet (2000) 2.02
Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol (1992) 1.99
Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol (2001) 1.99
Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes. J Biochem (1965) 1.97
Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med (1995) 1.97
Intramembranous fine deposit disease associated with collagen disorders: a new morphological entity? Virchows Arch A Pathol Anat Histopathol (1992) 1.97
Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1980) 1.97
Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity (1997) 1.94
Mammalian achaete-scute homolog 1 is transiently expressed by spatially restricted subsets of early neuroepithelial and neural crest cells. Genes Dev (1991) 1.90
Characterization of a new avian-like influenza A virus from horses in China. Virology (1992) 1.90
Structure and functional analysis of a marine bacterial carotenoid biosynthesis gene cluster and astaxanthin biosynthetic pathway proposed at the gene level. J Bacteriol (1995) 1.90
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem (2000) 1.89
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest (1998) 1.88
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int (2007) 1.86
Age-related changes in the subsets and functions of human T lymphocytes. J Immunol (1978) 1.82
Giant hydronephrosis due to a ureteral stone, and elevated serum levels of CA 19-9. Intern Med (1999) 1.80
Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci U S A (1996) 1.79
The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis (1993) 1.77
The narX and narL genes encoding the nitrate-sensing regulators of Escherichia coli are homologous to a family of prokaryotic two-component regulatory genes. Nucleic Acids Res (1989) 1.75
Presence of interchain disulfide bonds between two gene products that compose the secreted form of an antigen-specific suppressor factor. J Exp Med (1981) 1.73
The new lead citrate method for the ultracytochemical demonstration of activity of non-specific alkaline phosphatase (orthophosphoric monoester phosphohydrolase). Histochemie (1967) 1.71
Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol (1997) 1.71
Cloning of an intracellular Poly[D(-)-3-Hydroxybutyrate] depolymerase gene from Ralstonia eutropha H16 and characterization of the gene product. J Bacteriol (2001) 1.70
Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J Biochem (1990) 1.69
Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril (2000) 1.69
Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res (2000) 1.67
Review of influenza A virus in swine worldwide: a call for increased surveillance and research. Zoonoses Public Health (2013) 1.67
Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells. J Exp Med (1997) 1.66
Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation (2000) 1.65
Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels. Circulation (2001) 1.65
Three AML patients with existing or pre-existing intracerebral granulocytic sarcomas who were successfully treated with allogeneic bone marrow transplantations. Bone Marrow Transplant (1999) 1.65
Gastric leptin and Helicobacter pylori infection. Gut (2001) 1.63
Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity. J Immunol (1985) 1.61
Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci U S A (1997) 1.61
Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol (2004) 1.59
Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci U S A (1992) 1.59
On the mode of action of a new antifungal antibiotic, aculeacin A: inhibition of cell wall synthesis in Saccharomyces cerevisiae. J Antibiot (Tokyo) (1977) 1.59
Purification and properties of extracellular poly(3-hydroxybutyrate) depolymerases from Pseudomonas lemoignei. Biochim Biophys Acta (1985) 1.58
Ccm1, a regulatory gene controlling the induction of a carbon-concentrating mechanism in Chlamydomonas reinhardtii by sensing CO2 availability. Proc Natl Acad Sci U S A (2001) 1.57
Developmental and functional impairment of T cells in mice lacking CD3 zeta chains. EMBO J (1993) 1.56
Extracranial carotid aneurysm in Takayasu's arteritis. J Vasc Surg (2001) 1.55
CT and MR imaging of the "target sign" in metastatic brain disease. Eur Radiol (2000) 1.54
Ovarian fecundity in patients with endometriosis can be estimated by the incidence of apoptotic bodies. Fertil Steril (1998) 1.54
Enzymatic synthesis of poly-beta-hydroxybutyrate in Zoogloea ramigera. Arch Microbiol (1976) 1.54
Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces cleavage, nuclear translocation, and hyperphosphorylation of Notch2. Mol Cell Biol (2000) 1.54
Treadmill training with body weight support: its effect on Parkinson's disease. Arch Phys Med Rehabil (2000) 1.53
Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C. J Gastroenterol Hepatol (1999) 1.51
Retracted Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. Proc Natl Acad Sci U S A (2000) 1.51
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). Br J Cancer (2013) 1.50
Spontaneous regression of hepatocellular carcinoma and review of literature. J Gastroenterol Hepatol (2000) 1.50
Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis. Kidney Int (2001) 1.50
Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer (1993) 1.50
Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant (1998) 1.50
Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy. J Neuroimmunol (2005) 1.50
Purification and properties of beta-ketothiolase from Zoogloea ramigera. Arch Microbiol (1978) 1.48
Intraoperative coronary angiography using fluorescein. Ann Thorac Surg (1991) 1.48
Esophageal carcinoma metastatic to the stomach. A clinicopathologic study of 35 cases. Cancer (1985) 1.47
Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem (1995) 1.47
A pooled analysis of extremely low-frequency magnetic fields and childhood brain tumors. Am J Epidemiol (2010) 1.47
Cumulus mass maintains embryo quality. Fertil Steril (1994) 1.47